Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients

Table 2 Overall mortality in the total study cohort

Variable	Univariable analyses			Multivariable analysis
Variable	HR	95 % CI	p	HR	95 % CI	p
^aLow MAp44	1.73	1.24–2.41	0.001	1.52	1.08–2.14	0.017
^aCMV infection	1.46	1.05–2.03	0.025	1.17	0.83–1.66	0.38
Recipient age, per year	1.07	1.05–1.08	<0.001	1.06	1.05–1.08	<0.001
Donor age, per year	1.02	1.01–1.03	0.001	1.01	1.00–1.02	0.08
^aLiving donor	0.57	0.40–0.81	0.002	1.06	0.73–1.54	0.76
^aDiabetic nephropathy	1.38	0.91–2.09	0.13	2.13	1.39–3.42	<0.001
^aCoronary heart disease	2.58	1.84–3.62	<0.001	1.37	0.96–1.95	0.85
^aHypertensiv nephrosclerosis	1.90	1.34–2.69	<0.001	1.11	0.77–1-60	0.59
^aRecipient gender, female	1.15	0.83–1.58	0.40
^aPreemptive transplantation	0.85	0.56–1.29	0.44
^aInduction, basiliximab	1.20	0.88–1.65	0.25

ISSN: 1471-2369